Wyeth – Corporate Officers (2009)


– Employees: More than 51,500 people worldwide.
– Employee Networks: Women in Leadership and the Women’s Professional Network (site-based women’s organizations); Wyeth Latin Network; African Americans Dedicated to Value-Added Networking and Corporate Excellence; Wyeth RAINBOW Alliance (gay, lesbian, bisexual and transgender employee network).
– Diversity Program: Wyeth Corporate Diversity Department; Wyeth Diversity Council.
– Eagles Program: 2 year period program to expedite professional development and enhance leadership capabilities with the view of developing future leaders in Wyeth.
– Executive Leadership Program: 3 day, highly interactive program designed to be the first global, company-wide course that addresses how leaders can be effective in creating environments of teamwork, maintaining quality and developing people.
– Global Leadership Program: 8 day program to develop leadership and strategic thinking skills through a number of activities, including personal assessments, case studies and interactive team challenges.
– Participation in the INROADS Internship program.
– Scholarships to the United Negro College Fund, and the Urban League of Philadelphia (2005-2007).
– Wyeth supports the National Black MBA Association, the National Society of Hispanic MBAs and the National Association of Black Accountants.

Corporate Officers

Timothy P. Cost
– Senior Vice President Corporate Affairs.
– Executive Vice President Corporate Affairs (2003-2008); Senior Vice President Corporate Affairs (2008) at ARAMARK Corporation.
– Senior Vice President of Corporate Affairs at Pharmacia Corporation (2001-2003).
– Vice President of Investor Relations and Corporate Intelligence for Bristol-Myers Squibb Company (1996-2001).

Gregory Norden (1958-)
– Senior Vice President and Chief Financial Officer (2007).
– Positions of increasing responsibility (1989); Senior Vice President Finance and Chief Financial Officer and American Home Food Products; Senior Vice President and Chief Financial Officer at Wyeth Laboratories; Executive Vice President and Chief Financial Officer at Wyeth Pharmaceuticals (2000).
– Employed by Arthur Andersen & Company in New York.
– Undergraduate degree from the State University of New York and Master of Science in Accounting from C. W. Post College.

Thomas Hofstaetter, Ph.D. (1948-)
– Senior Vice President Corporate Business Development (2004).
– Senior Vice President Corporate Development at Aventis.
– Senior Vice President, Business Development and Strategic Planning, for Hoechst Marion Roussel (1995-1998).
– Executive Managing Director of Hoechst Japan Pharmaceuticals (1991-1994).
– Research Scientist (1978) and Head of Research (1988) at Behringwerke AG in Germany.
– Ph.D. in Biochemistry/Molecular Biology from the University of Tuebingen in Germany.

Mary Katherine Wold (1953-)
– Vice President of Taxes (2002) with responsibility for worldwide tax matters; Senior Vice President of Tax and Treasury (2005); Senior Vice President of Finance (2007).
– Partner (1988), and head of worldwide tax practice group (1995-2000) in the New York law firm of Shearman & Sterling.
– Undergraduate degree from Hamline University, where was elected member of Phi Beta Kappa; J.D. from the University of Michigan Law School.

Douglas A. Dworkin (1948-)
– Vice President and Deputy General Counsel (2004).
– Partner at Arnold & Porter in Washington D.C. (1985-1997 and 2001-2004).
– Deputy General Counsel and then General Counsel in the Department of Defense (1997-2001).
– Executive Assistant to then-Deputy Secretary of State Warren Christopher (1979-1981).
– Foreign Service Officer with the Department of State, stationed in Brussels.
– Law clerk to Chief Judge David L. Bazelon of the United States Court of Appeals for the District of Columbia Circuit.
– Bachelor of Arts degree from Oberlin College, Master of Arts degree in International Relations at Yale University, and Juris Doctor degree from Yale Law School (1976).

Other Members

René R. Lewin (1946-)
– Vice President Human Resources (1994); Senior Vice President Human Resources (2004)
– Variety of management positions; President and General Manager at Eli Lilly Canada; Executive Director Corporate Affairs; Executive Director Human Resources at Eli Lilly and Company.
– Degree in Industrial Management from Purdue University and Masters in Business Administration from Butler University.

Marily H. Rhudy (1948-)
– Assistant Vice President Professional Relations for Wyeth-Ayerst (1993); Vice President Public Affairs for domestic pharmaceutical division (1994); Vice President Global Public Affairs for Wyeth-Ayerst Pharmaceuticals (1997); Vice President Corporate Public Affairs (1997); Senior Vice President Public Affairs (2004).
– Appointment to the White House working on health care reform (1993).
– President and Chair of the Board of Trustees of the American Pharmaceutical Association in Washington D.C.
– Bachelor of Science Degree in Pharmacy from the University of Kansas, University of Kansas Distinguished Alumnae award (1998).

Michael Kamarck, Ph.D. (1951-)
– Executive Vice President at Wyeth Pharmaceuticals (2007). Responsible for all aspects of technical operations and product supply, including Pharmaceutical, BioPharma, Vaccine, Consumer Healthcare and Nutritional units.
– Biotechnology and pharmaceutical research for Bayer AG; and Senior Vice President of Operations for Bayer Biologicals.
– Fellow of the Leukemia Society of America at Yale University (1979-1982).
– Graduated from Oberlin College and Ph.D. in Biochemistry from the Massachusetts Institute of Technology.

Charles A. Portwood
– President Global Supply Chain (2001); Executive Vice President at Wyeth Pharmaceuticals.
– Senior Vice President Strategy and Industrial Excellence at Aventis (1970-2001).

Daniel J. McIntyre
– Vice President Corporate Communications at Wyeth Pharmaceuticals (2008).
– Executive committee of the Rutgers University Foundation.
– Member of the Public Relations Society of America.
– Managing Director of the healthcare practice of Fleishman-Hillard International Communications.
– Senior level Communications and Public Policy positions for Pharmacia Corporation, Bayer Corporation‘s Pharmaceutical Division, the Bristol-Myers Squibb Company, and Hoffmann-La Roche Inc.
– Boards of trustees of Caldwell College, the American Association for World Health, the New England Healthcare Institute, and Connecticut United for Research Excellence.
– Honors graduate of Seton Hall University, and MPA from Rutgers University.

Mikael Dohlsten, M.D., Ph.D.
– President of Research at Wyeth Pharmaceuticals (2008).
– Executive Vice President within Pharmaceutical Research & Development/Medicine at Boehringer Ingelheim.
– Leadership roles in pharmaceutical research including positions with AstraZeneca and Pharmacia & Upjohn.
– Adjunct Professor in Immunology at the Medical Faculty in Lund.
– Ph.D. in tumor immunology and M.D. from the University of Lund in Sweden. Studied virology and cell biology at the Weizmann Institute in Israel.

Robert R. Ruffolo Jr., Ph.D. (1950-)
– President of Research and Senior Vice President (2000-2008) at Wyeth Pharmaceuticals.
– Scientific Advisory Board and Board of Directors at Trevena Inc. (2009).
– 17 years at SmithKline Beecham.
– 6 years at Lilly Research Laboratories.
– B.S. degree in Pharmacy (1973) and Ph.D. degree in Pharmacology (1976) from The Ohio State University.

Emilio A. Emini, Ph.D.
– Executive Vice President Vaccines Research and Development at Wyeth Pharmaceuticals (2005). Strategic leadership of an organization of approximately 600 scientists and professional support employees responsible for research and development for Wyeth Vaccines, focused on research areas that include pneumococcal disease, bacterial meningitis, respiratory diseases, Alzheimer’s disease, HIV infection, and sexually transmitted diseases.
– Fellow of the American Academy of Microbiology.
– Senior Vice President for Vaccine Development at the International AIDS Vaccine Initiative (2004-2005).
– Positions of increasing responsibility in vaccine and antiviral therapeutic research; Senior Vice President Vaccines and Biologics Research at Merck & Co. Inc. (1983-2004).
– Ph.D. in Microbiology from Cornell University Graduate School of Medical Sciences (1980).
– Postdoctoral Fellow in the Department of Microbiology at the State University of New York at Stony Brook (1980-1983).

Mahdi Fawzi
– Former Executive Vice President Preclinical Development at Wyeth Pharmaceuticals.
– President Global Research and Development at Warner Chilcott plc since October 2009.
– Positions with Warner Lambert, The Procter & Gamble Company and Pfizer Inc.
– Bachelor of Science in Pharmacy from the University of Bagdad and Masters and Doctorate in Pharmaceutical Chemistry from the University of Michigan.

Kevin F. Brady (1956-)
– Senior Attorney (1993); Deputy Chief Counsel for Wyeth Pharmaceuticals and Senior Corporate Counsel (1997); Vice President and Deputy Chief Counsel for Wyeth Pharmaceuticals (1999); Assistant General Counsel (2000); Senior Vice President and Chief Counsel for Wyeth Pharmaceuticals and member of the Executive Management Team (2001); Associate General Counsel (2002); Vice President (2004).
– B.A. in Public Affairs from Princeton University; J.D. from the University of Virginia.

Timothy T. Slater (1947-)
– Assistant General Counsel (1994); Associate General Counsel (1999); responsibility for the legal affairs of Wyeth Consumer Healthcare and Fort Dodge Animal Health; head of Law Department operations; Vice President (2004).
– Vice President and General Counsel at A.H. Robins Company (acquired by Wyeth, 1989).
– B.A. in Political Science from the University of Kentucky; J.D. from Emory University.

Eileen M. Lach (1951-)
– Special Counsel International (1989); Assistant General Counsel (1992); Corporate Secretary (1997); Associate General Counsel International (2000); Vice President Corporate Secretary and Associate General Counsel (2004).
– Partner at Drinker, Biddle & Reath.
– B.A. from the University of Minnesota; J.D. from New York University School of Law; Master’s degree from Princeton University.

Gary L. Stiles, M.D.
– Executive Vice President and Chief Medical Officer, responsible for the Clinical
Research & Development organization, which manages all clinical trial studies
for new products, and Global Medical Affairs, which supports the marketed
products through further clinical development, medical education and physician
communications for Wyeth Pharmaceuticals (2004).
– Young Investigator Award from the American College of Cardiology, the American Heart Association Louis N. Katz Basic Science Research Prize, and 5 pharmaceutical patents.
– Vice President and Chief Medical Officer for the Duke University Health System (1999-2004).
– Medical Director for the Duke University Health System Network, responsible for the recruitment and implementation of the external physician network.
– Helped create and chaired (1996) the management committee of PrimaHealth, Physician Association of more than 1,000 physicians including both community and Duke physicians.
– Cardiology Fellow (1981); progressive leadership roles in Department of Medicine; Chief of Cardiology; Director of the Cardiology Training Program; and Vice-Chair of the Department of Medicine at Duke University.
– Medical school at Vanderbilt University School of Medicine and residency in cardiology at Vanderbilt Hospital.

William Ruane (1955-)
– Special Counsel Litigation (1988); Assistant General Counsel (1993); Associate General Counsel (2000); Vice President and Associate General Counsel Litigation (2003).
– B.A. from New York University (1977); J.D. from Fordham Law School (1980).

William Haskel (1961-)
– Positions of increasing responsibility in Law Department (1992); Assistant Vice President Planning; Secretary of the Management Committee; Vice President and Associate General Counsel Corporate (2003).
– B.A. from Franklin & Marshall College (1983); J.D. from the National Law Center at George Washington University (1986).

Lawrence V. Stein (1950-)
– Vice President and Deputy General Counsel (2000-2001); Senior Vice President (2001) and General Counsel (2003).
– Associate General Counsel and Senior Vice President and Chief Legal Counsel of Wyeth-Ayerst and Genetics Institute (1997-2000).
– Senior Vice President and General Counsel at Genetics Institute (1992-1997).
– Practice (1976) and Partner (1984) at Arnold & Porter.
– J.D. from the University of Pennsylvania Law School (1976); A.B. from Columbia College (1971); and M.A. from Cornell University (1974).

Jessica Leigh Stoltenberg (1955-)
– Vice President Corporate Communications (2003).
– Director of Corporate Communications (1996); Vice President Global Public and Media Relations (1999) at Medtronic Inc.
– Public Relations Executive for Tunheim Santrizos Public Relations.
– Bachelor of Arts degree from Baylor University in Waco, Texas.



A %d blogueros les gusta esto: